pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy
Small interfering RNA (siRNA) has a promising future in the treatment of ocular diseases due to its high efficiency, specificity, and low toxicity in inhibiting the expression of target genes and proteins. However, due to the unique anatomical structure of the eye and various barriers, delivering nu...
Saved in:
Main Authors: | Shuai Guo (Author), Chunhui Li (Author), Changrong Wang (Author), Xiaowen Cao (Author), Xinyue Liu (Author), Xing-Jie Liang (Author), Yuanyu Huang (Author), Yuhua Weng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficient ocular delivery of siRNA via pH-sensitive vehicles for corneal neovascularization inhibition
by: Xiaowen Cao, et al.
Published: (2023) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy
by: Bo Hu, et al.
Published: (2023) -
Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
by: Olga Osipova, et al.
Published: (2020) -
Targeting Neuroinflammation in Neovascular Retinal Diseases
by: Tianxi Wang, et al.
Published: (2020)